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Rationale for extensive lymphadenectomy in early gastric carcinoma
K Miwa, I Miyazaki, H Sahara, T Fujimura, Y Yonemura, M Noguchi and R Falla
Surgery II, School ofMedicine, Kanazawa University, Takaramachi 13-1, Kanazawa 920, Japan.
Summary The incidence of nodal metastasis in early gastric carcinoma (EGC) is 10-20%. However, the
optimal nodal dissection for early gastric carcinoma has not been established. A retrospective study was
conducted in 392 consecutive patients who underwent potentially curative distal gastrectomy for EGC between
1962 and 1990. Of these 295 patients treated after September 1972 were prospectively entered into an extensive
lymphadenectomy protocol. These patients were compared with 97 patients with simple gastrectomy in respect
of the causes of death after surgery and the 10 year disease-specific survival rate. The incidence of nodal
metastasis in early gastric carcinoma patients was 13.0%. Operative mortality from extensive lymphadenec-
tomy was almost the same as from simple gastrectomy (2.0% and 2.1% respectively). Extensive lymphadenec-
tomy provided a significantly higher 10 year survival rate than limited lymph node dissection (97.9% vs 88.1%
respectively; P<0.005). Among patients with nodal metastasis, the survival rate following extensive lym-
phadenectomy was significantly higher than that after simple gastrectomy (87.5% vs 55.6%; P = 0.018).
Among patients without nodal metastasis, there was no difference between the two groups in the survival rate
(99.4% and 96.7% respectively; P = 0.12). Multivariate analysis using the Cox proportional hazards model
disclosed two significant independent prognostic factors on disease-specific survival, the nodal involvement
(risk ratio: 8.4; P<0.0001) and the extent of lymph node dissection (risk ratio: 5.8; P<0.005). Extensive
nodal dissection appears to prevent recurrence and to improve the cancer-specific survival in EGC patients
with nodal metastasis.
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Although its incidence is decreasing, gastric carcinoma still
ranks as the second leading cause of cancer death in the
world. In order to improve the outcome in gastric carcinoma,
it is important that it be detected at an early stage and
treated adequately. Early gastric carcinoma (EGC) is defined
as carcinoma with limited invasion into the gastric mucosa or
submucosa with or without metastasis. EGC has a 10-20%
incidence of nodal metastasis (Maruyama et al., 1987; Ohta
et al., 1987; Marczel et al., 1988; Lehnert et al., 1989; Per-
civale et al., 1989; Farley et al., 1992; Maehara et al., 1993).
Nevertheless, the optimal extent of lymph node dissection for
EGC has not been well established. Japanese surgeons nor-
mally perform extensive lymphadenectomy for EGC because
a certain proportion of these patients have lymph nodal
involvement and carcinoma recurrence is not rare. In con-
trast, most surgeons in Western countries do not use aggres-
sive surgery (Cuschieri, 1986; Heberer et al., 1988; Irvin and
Bridger, 1988; Heesakkers et al., 1994), perhaps because of
uncertainty regarding improvement in the survival rate and
the high operative risk associated with extensive lymph node
dissection (Dent et al., 1988; Heberer et al., 1988; Irvin and
Bridger, 1988).
To evaluate the therapeutic value of extensive lym-
phadenectomy in EGC, we analysed retrospectively the
causes of death after surgery and compared the 10 year
disease-specific survival rate in patients who had received
extensive lymphadenectomy with patients who had received
simple gastric resection.
Patients and methods
Patients
Between August 1962 and May 1990, 2088 patients under-
went gastric resection at Surgery II, University Hospital,
School of Medicine, Kanazawa University. A total of 503
(24.0%) of these patients had EGC. Seventy-one patients
who received a total or proximal gastrectomy for EGC
located in the upper third of the stomach and 35 patients
with multifocal gastric carcinoma were excluded from this
study. Five patients who underwent non-curative procedures,
such as those with hepatic metastasis, Virchow's nodal
involvement, and inadequate local resection were also ex-
cluded. Thus, the present study included 392 patients with
EGC who underwent potentially curative distal gastric resec-
tion. Of these 392 patients, 295 patients were treated by
extensive lymph nodes dissection (ELND) and 97 patients
were treated by distal gastrectomy with limited lymph node
dissection (LLND). ELND was performed beginning in
September 1972. The LLND group consisted of 68 patients
before September 1972 and 29 patients after. Each surgical
procedure is outlined below. The subjects were followed up,
and the effect of lymph node dissection on their 10 year
disease-specific survival was evaluated. The operative and
pathological findings were assessed according to the guide-
lines of the Japanese Research Society for Gastric Cancer
(1981). The median age of the patients at the time of oper-
ation was 59 years, with a range of 18-84 years. There were
271 males (69%) and 121 females (31%).
Surgery
The ELND gastrectomy was performed as follows: the entire
greater omentum, superior leaf of the mesocolon, pancreatic
capsule and lesser omentum were removed en bloc with the
cancerous distal portion of the stomach. Each of the supply-
ing gastric arteries was ligated and divided at its origin, and
the group 1 lymph nodes (nl), namely those along the lesser
and greater curvatures, as well as the supra- and infra-pyloric
lymph nodes, were completely dissected. In addition, the
group 2 lymph nodes (n2) located at the right side of the
cardia, and along the left gastric, common hepatic and
coeliac arteries were also dissected. In some patients, addi-
tional group 3 lymph node (n3) dissection was performed at
the hepatoduodenal ligamentum, retropancreatic area and
along the superior mesenteric vein. This nodal dissection is
similar to R2/R3 in the Japanese rules.
The LLND gastrectomy was conservatively performed in
the same manner as distal gastrectomy for ulcer disease; the
gastrocolic ligamentum was divided between the stomach and
the transverse colon. The right and left gastroepiploic arteries
and the right gastric artery were ligated separately and
divided near the gastric resection margin. The left gastric
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This procedure included removal of only the perigastric
lymph nodes along the lesser and greater curvatures to the
extent required for gastric resection. This procedure is similar
to Ro/Rl in the Japanese rules.
The reconstruction was made using Billroth I or II anas-
tomosis.
Pathological examination
The resected stomach was opened along the greater curvature
and macroscopically evaluated intrasurgically. The macro-
scopic appearance of the tumour was identified and its
greatest diameter measured. After surgery, each lymph node
was dissected by the attending surgeon, and classified accord-
ing to the lymph node designations used in the Japanese
Gastric Cancer Study. The gastric specimen was fixed to a
cork plate, which was then immersed in 15% formalin solu-
tion for more than 48 h. Serial sections parallel to the lesser
curvature, 3-5 mm in thickness, including the entire
cancerous lesion of the stomach, were prepared. The his-
tology of each dissected lymph node was evaluated by
examining a single central cross-sectional slice. The slices of
tissue were stained with haematoxylin-eosin. The EGC was
macroscopically classified as non-ulcerated (I, Ila, Ila + lIc,
Ila + Ilb or Ilb) or ulcerated (Ilc, Ilc + III, III + TIc, or III).
Histologically, the tumour was evaluated either as differ-
entiated, including papillary, well-differentiated or moderate-
ly differentiated tubular or as undifferentiated, including
poorly differentiated, mucinous, and signet ring cell type.
Analysis
The clinical and pathological data for the patients were
entered into a personal computer (PC-9801 VX, NEC,
Tokyo) using the Beccel Mark-II software system (Beccel,
Tokyo). For all patients, follow-up information including the
cause of death was obtained using a yearly routine examina-
tion at our department, or questionnaire or telephone contact
with the patient, local doctor or family. The patients were
followed up until death or until December, 1994. The follow-
up rate was 99.0% (388/392). The average duration of
follow-up was 14 years, with a range of 4-27 years. The
survival rates were calculated by use of Kaplan-Meier
estimate (Kaplan and Meier, 1958), and patients who died
due to a cause unrelated to gastric carcinoma, including
operative death, death due to other disease or malignancy,
other cause of death, were treated as censored observations
at the time of death. The treatment in one patient in the
ELND group, who died of unknown causes, was regarded as
failed in this analysis. Univariate analysis of the relation to
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survival after surgery was performed for the following ten
clinicopathological variables; age (<59 years or .59); sex
(female or male); nodal dissection (LLND or ELND); recon-
struction (Billroth I/Billroth II); location of tumour (the
distal or middle third of the stomach); macroscopic type
(non-ulcerated or ulcerated); tumour size (>3.0 cm or
<3.0 cm); depth of invasion (submucosal or mucosal); nodal
involvement (present or absent); number of nodes positive
(one, or two or more); and histological type (differentiated or
undifferentiated). To analyse the survival curves in groups of
patients, the log-rank test (Peto and Pike, 1973) was used.
Multivariate analysis of independent prognostic factors
shown to be prognostically significant, with a P-value near
0.05 in the univariate analysis, was performed using the Cox
proportional hazards model (Cox, 1972). Operative mortality
was defined as in-hospital mortality. All other statistics were
performed using the chi-square test with the Fisher's exact
test for categorical variables, and the Wilcoxon signed rank
test for continuous variables. A difference was considered to
be significant when the P-value was less than 0.05.
Results
Clinicopathological characteristics
Table I shows the overall patient characteristics ofpatients in
the ELND and LLND groups. The demographics and histor-
ical risk factors in the patients treated with ELND were
similar to those in the patients treated with LLND with the
exceptions of number of dissected nodes and number of
nodes positive.
Nodal metastasis
Nodal metastasis was found in 51 patients (13.0%). The
incidence of nodal metastasis was 12.2% in the ELND group
and 15.5% in the LLND group. This difference was not
significant (P = 0.51). The number of dissected lymph nodes
in the ELND group was significantly larger than that of the
LLND group [medians (range): 37 (8-104) vs 15 (6-29);
P<0.0001] and the average number of metastatic nodes was
also significantly increased in the former [median (range): 2.5
(1-26) vs 1 (1-6); P<0.005). Of the 295 patients who
underwent the ELND procedure, lymph nodal metastasis was
limited to nl(+) in 25 patients (8.5%), extended to n2(+) in
nine (3.1%), and even to n3(+) in two (0.6%).
Cause ofdeath
As of December 1994, 277 patients were alive, 111 had died
and the remaining four patients had been lost to follow-up.
Table I Patient characteristics
Characteristic
Age
Sex (male/female)
Reconstruction
(Billroth I/II)
Tumour location (middle
/distal third of stomach)
Macroscopic type
(non-ulcerated/ulcerated)
Depth of invasion
(mucosal/submucosal)
Nodal involvement
(present/absent)
Number of dissected nodes
Number ofpositive nodes
Histological type
(differentiated/undifferentiated)
Overall ELND
(n =392) (n = 295)
59 (18-84)' 59 (18-84)'
271/121 206/89
336/56 257/38
182/210 137/158
126/266 89/206
210/182 164/131
51/341
35 (6-104)'
2 (1 -26)'
271/121
36/259
37 (8-104)-
2.5 (1-26)a
197/98
ELND, extensive lymph node dissection; LLND, limited lymph node dissection. aMedian (range). bWilcoxon signed-rank test. cThe Chi-square test.
Group
LLND
(n =97)
56.5 (25-80)a
65/32
79/18
45/52
37/60
46/51
15/82
15 (6-59)a
1 (1-6)a
74/23
pa
o.Iob
0.69c
0.22c
0.75c
0.18c
0.20c
0.58c
<0.OOOlb
<O.OOsb
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The causes of death are shown in Table II. The 10 year
mortality rate for recurrence of gastric carcinoma was
relatively low (4.8%). The ELND group had a significantly
lower 10 year mortality rate for recurrence than the LLND
group (2.1% vs 11.9%; P<0.005). There was no significant
difference in the operative mortality rate between the two
groups [six deaths (2.0%) in the ELND group and two
(2.1%) in the LLND group]. The most prevalent cause of
death was disease other than gastric carcinoma (14.4%), such
as cerebrovascular, coronary or pulmonary disease, followed
by other malignancy (5.6%).
Recurrence
The clinical features of the 14 patients with recurrence are
summarised in Table III. Ten patients had lymph nodal
involvement and four did not. All patients with recurrence
were dead within 11 years after surgery. Eight patients died
within 5 years after surgery, and the other six (43%) died
within 5-11 years after surgery. The main recurrence mode
was local in seven patients, hepatic in five and peritoneal in
two.
ELND group (87.5% and 99.4%; P<0.001) and in the
LLND group (55.6% and 94.6%; P<0.0001).
As shown in Figure 1, the 10 year survival rate in the
ELND group was 97.9%, while in the LLND group it was
88.1% (P<0.005). The 10 year survival rate in patients with
nodal metastasis in the ELND group was 87.5%, significant-
ly higher than the 55.6% in those with nodal metastasis in
the LLND group (P = 0.018) (Figure 2). On the other hand,
no significant difference was found between the ELND and
LLND group patients without nodal metastasis in 10 year
survival rate (99.4% and 96.7% respectively; P = 0.12)
(Figure 3). The 10 year survival rate was 82.0% in the group
with two or more positive nodes and 78.3% in that with one
positive node; this difference was not significant (P = 0.8).
When the patients were classified according to the depth of
carcinoma invasion, the 10 year survival rate in those in the
ELND group with submucosal carcinoma was significantly
higher than in those in the LLND group with submucosal
carcinoma (96.3% vs 82.2%; P = 0.013). On the other hand,
no difference was found between the ELND and the LLND
groups in the 10 year survival rates of patients with mucosal
carcinoma (99.1% and 95.2% respectively; P = 0.3) (Figure
4).
Survival
The overall 5 and 10 year survival rates in the EGC patients
was 97.7% and 95.2% respectively.
The 10 year survival rate in the patients with nodal meta-
stasis was 77.4%, whereas in those without metastasis it was
98.0%. This difference is significant (P<0.0001). There was
also a significant difference in the 10 year survival rate
between patients with and without nodal metastasis in the
Table II Cause ofdeath
Number (%)a ofpatients
Group
Cause Total ELND LLND
Recurrence 14 (4.8) 4 (2.1)b 10 (I 1.9)
Operative 8 (2.0) 6 (2.0) 2 (2.1)
Other disease 64 (14.4) 42 (13.4) 22 (16.6)
Other malignancy 23 (5.6) 14 (5.5) 9 (6.0)
Other 1 (1.5) 1 (2.4)
Unknown 1 (1.0) 1 (1.6)
Total 111 (24.6) 68 (21.5) 43 (32.3)
ELND, extended lymph nodedissection; LLND, limited lymph node
dissection. aValues in parenthesis are mortality rates at 10 years after
surgery. bThe rate of death due to recurrence in patients treated with
ELND was significantly lower than that of those treated with LLND
(P<0.005).
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Figure 1 Disease-specific survival curves for patients with early
gastric carcinoma who underwent ELND or LLND distal gas-
trectomy; Kaplan-Meier method, the log-rank test.
ELND, extensive lymph node dissection; LLND, limited lymph
node dissection. Deaths other than gastric carcinoma were cen-
sored at the time of death. P<0.005.
Table III Clinical features of patients with recurrence
Tumour characteristics
Nodal Histo-
Patient Age Macroscopic Tumour Depth of involve- logical Node Survival Mode of
no. (years) Sex Location type size (cm) invasion ment type dissection time recurrence
1 64 F A NU 2.5 SM + Dif LLND 7 months Local
2a 68 M A U 2.2 M + Dif LLND 7 years, 7 months Local
3 67 M A NU 5.3 SM + Dif LLND 2 years, 3 months Hepatic
4a 38 M Mi U 6.2 M - Dif LLND 10 years, 3 months Local 5 55 M M NU 4.0 SM + Dif LLND 4 years, 11 months Peritoneal
6 54 M Mi U 1.5 SM - Dif LLND 3 years, 11 months Hepatic
7 33 F Mi NU 5.0 SM - Undif LLND 9 years, 4 months Local
8 55 M Mi U 9.5 SM + Dif LLND 5 years, 6 months Local
9 50 F A U 2.8 SM - Dif LLND 10 years, 0 months Peritoneal
10 69 M A NU 8.0 SM + Dif LLND 11 months Hepatic I1 65 M A NU 3.5 SM + Dif ELND 3 years, 7 months Hepatic
12 48 F M U 4.0 M + Dif ELND 5 years, 9 months Local
13 63 M A U 2.0 SM + Undif ELND 4 years, 4 months Local
14 60 F A NU 3.3 SM + Dif ELND I year, 8 months Hepatic
aPatients with resection ofrecurrence; at 6 years 10 months after surgery in Patient 2 and at 1 year 3 months in Patient 4. A, distal third ofthe
stomach; Mi, middle third ofstomach; U, ulcerated; NU, non-ulcerated; M, mucosa; SM, submucosa; Dif, differentiated; Undif, undifferentiated;
ELND, extensive lymph node dissection; LLND, limited lymph node dissection.
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Figure 2 Disease-specific survival curves for early gastric car-
cinoma patients with nodal metastasis according to extent of
lymph node dissection; Kaplan-Meier method, the log-rank test.
ELND, extensive lymph node dissection; LLND, limited lymph
node dissection. Deaths other than gastric carcinoma were cen-
sored at the time of death. P = 0.018.
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Figure 4 Disease-specific survival curves for patients with
mucosal or submucosal early gastric carcinoma according to
extent of lymph node dissection. Significant difference was
observed between the ELND SM and the LLND SM. Kap-
lan-Meier method, the log-rank test. ELND, extensive lymph
node dissection; LLND, limited lymph node dissection. M,
mucosal; SM, submucosal. Deaths other than gastric carcinoma
were censored at the time of death. P = 0.013.
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Figure 3 Disease-specific survival curves for early gastric car-
cinoma patients without nodal metastasis according to extent of
lymph node dissection. There was no significant difference
between two groups; Kaplan-Meier method, the log-rank test.
ELND, extensive lymph node dissection; LLND, limited lymph
node dissection. Deaths other than gastric carcinoma were cen-
sored at the time of death. P = 0.12.
Univariate andmultivariate analysis
Table IV shows the results of univariate analysis of the ten
factors examined as potential prognostic indicators. Uni-
variate analysis indicated that nodal involvement, nodal
dissection and depth of invasion were significantly related to
outcome (P<0.0001, P<0.005 and P<0.01 respectively).
Multivariate analysis (Table V) revealed that the factor most
highly correlated with outcome was nodal involvement (risk
ratio: 8.4; P<0.0001), followed by node dissection (risk
ratio: 5.8; P<0.005). Multivariate analysis indicated that the
depth of invasion and macroscopic type were not
significantly related to outcome.
Discussion
Until now it has not been determined whether limited or
aggressive lymph node dissection should be employed for
EGC. To our knowledge there is only one study (Kodama et
al., 1981) in which limited or aggressive lymph node dissec-
tion for EGC was compared. In that study, the 5 year
survival rate of patients with extensive lymph node dissection
did not differ from those with simple resection, but the
sample size was not as large.
In the present study, 392 patients with EGC were
evaluated and followed up 10 years after surgery. The reason
why we followed for such a long time is that cancer death
occurs often 5-10 years after surgery (Itoh et al., 1989;
Furusawa et al., 1991; Moreaux and Bougaran, 1993; Sano et
al., 1993). Indeed, the present study revealed that only 43%
of the recurred patients died 5 years after surgery. The 10
year survival rate of patients wtih ELND gastrectomy was
significantly higher than that of patients with LLND gastrec-
tomy. This difference was observed only in patients with
nodal metastasis, and not in those without metastasis. Thus
ELND gives a survival benefit to node-positive EGC
patients.
When more extensive lymph node dissection is performed,
the capacity to stage patients by nodal status is enhanced.
The impact of screening programmes on clinical presentation
is a fact which has been reported in other cancers as well.
Stage shifting must be considered in interpreting the present
results. We conducted a thorough pathological examination
of all lymph nodes in the resected specimens in the two
groups, and found that in the extensive lymphadenectomy
group, not only was the total number of dissected nodes
increased, but also the number of metastatic nodes was in-
creased by the ELND procedure. However, no increment in
the incidence of patients with positive nodes in the ELND
group was observed compared with the LLND group. The
extended procedure did not result in any significant stage
shifting in these patients.
There are some reports that EGC patients with nodal
metastasis have a poorer prognosis than those with cancer-
negative nodes (Habu et al., 1986; Marczell et al., 1988;
Inoue et al., 1991; Lawrence and Shiu, 1991; Santoro et al.,
1991; Guadagni et al., 1993; Pinto et al., 1994). This aspect is
supported by our findings not only for the LLND group but
also for the ELND group. Although ELND brought about a
significantly increased number of positive lymph nodes, the
survival rate of patients with nodal metastasis in the ELND
group was significantly increased from that in the LLND
group. These observations suggest that most of the EGC
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Table IV Results ofunivariate analysis ofrelationship ofclinical and pathological
variables to disease-specific survival rate in patients with early gastric carcinoma
10 year 95%
Number of survival confidence
Characteristic patients rate (%)a interval pb
Age (years) 0.87
<59 197 94.4 90.9-97.9
" 59 195 94.8 91.5-98.1
Sex 0.89
Female 121 93.9 88.5-99.3
Male 271 95.7 92.9-98.5
Nodal dissection <0.005
LLND 97 88.1 80.7-95.5
ELND 295 97.9 96.1-99.7
Reconstruction 0.21
Billroth I 336 96.3 94.0-98.6
Billroth II 56 92.0 93.1-100
Location of tumour 0.80
Distal 210 94.9 91.3-98.5
Middle 182 95.8 92.5-99.1
Macroscopic type 0.063
Non-ulcerated 126 93.0 87.8-98.2
Ulcerated 266 96.2 93.9-99.1
Tumour size (cm) 0.71
3.0 196 93.0 87.8-98.2
<3.0 196 96.2 93.9-99.1
Depth of invasion <0.01
Submucosal 182 91.6 86.9-96.3
Mucosal 210 98.5 96.4-100
Nodal involvement <0.0001
Present 51 77.4 64.9-89.9
Absent 341 98.0 96.0-100
Number of positive nodes 0.80
One 21 78.3 59.4-97
Two or more 30 82.0 67.7-96.3
Histological type 0.17
Differentiated 271 93.9 90.4-97.4
Undifferentiated 121 97.6 94.3-100
ELND, extensive lymph node dissection; LLND, limited lymph node dissection.
aDeaths other than gastric carcinoma were censored at the time ofdeath. bLog-rank
test.
Table V Multivariate analysis of prognostic factors for 10 year
disease-specific survival
Risk 95% confidence
Characteristic P ratio interval
Nodal involvement
Present/absent <0.0001 8.4 2.9-24.9
Node dissection
LLND/ELND <0.005 5.8 2.0-16.6
Macroscopic type
Non-ulcerated/ulcerated 0.51
Depth of invasion
Submucosal/mucosal 0.21
ELND, extensive lymph nodedissection; LLND, limited lymph node
dissection. Deaths other than gasfric carcinoma were censored at the
time of death. Cox proportional hazards model.
patients with nodal metastasis can be cured by ELND and
that nodal metastasis does not indicate systemic disease.
When the lymph nodes are enlarged, metastasis can
generally be easily diagnosed by gross examination. However,
when they are not enlarged, surgeons cannot easily determine
intraoperatively whether metastatic foci are present or not.
The nodal status of EGC are generally of the latter type
(Sano et al., 1994). Although frozen lymph node sections
certainly provide reliable information, the ability to examine
a large number of lymph nodes is limited. Thus, the nodal
status cannot be accurately diagnosed before the post-
operative pathological examination.
Some reports indicate that the survival rate differs accord-
ing to whether the depth of invasion is mucosal or sub-
mucosal (Gentsch et al., 1981; Takagi et al., 1987; Craanen et
al., 1991; Lawrence and Shiu, 1991; Inoue et al., 1991;
Guadagni et al., 1993; Moreaux and Bougaran, 1993). It is
well established that, as the depth of gastric carcinoma
invasion into the gastric wall increases, the frequency and the
degree of nodal metastasis also increases. Lymph nodal
metastasis is present in 1.8-4.8% of EGC patients with
mucosal invasion, but in 16.7-23.8% of those with sub-
mucosal invasion (Habu et al., 1986; Korenaga et al., 1986;
Ohta et al., 1987; Iriyama et al., 1989; Sowa et al., 1989;
Inoue et al., 1991; Moreaux and Bougaran, 1993). Thus, the
local invasiveness of EGC may be correlated with the sur-
vival rate (Lawrence and Shiu, 1991). However, in the pres-
ent study, the survival of patients with submucosal invasion
who underwent the ELND procedure was significantly higher
than those who underwent the LLND procedure, and almost
similar to that of patients with mucosal invasion who under-
went either procedure. These findings indicate that the
ELND procedure should be used in patients with submucosal
carcinoma.
The reported incidence of nodal metastasis was 12.9%
among 791 patients with EGC treated at the Cancer Institute
Hospital, Tokyo (Takagi et al., 1987); 8.8% in nl(+), 3.2%
in n2(+) and 0.5% in n3(+). Our study demonstrated almost
the same incidence of metastasis, 8.5% in nl(+), 3.1% in
n2(+) and 0.6% in n3(+). When dealing with small number
of patients, the low incidence in either n2(+) or n3(+) may
be insignificant, a fact that could mask the superiority of
ELND for EGC with nodal metastasis.
In contrast, it is debatable whether aggressive surgery
should be considered for mucosal carcinomas. Lymph node
metastases do occur in patients once the basement membrane
has been breached since there are lymphatics within the
deeper layers ofthe mucosa, above the submucosa. Korenaga
et al. (1986) recommended lymph node dissection even in
patients with mucosal carcinoma, because they found meta-Nodedissection forearlygastrkcarcinoma
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stases to distant lymph nodes in three of 568 patients with
mucosal EGC. Lawrence and Shiu (1991) also emphasised
that extended lymphadenectomy should be used in all
patients with EGC, even in those in whom mucosal invasion
is identified. However, in our study, the survival rate for
patients with mucosal carcinoma treated using the ELND
procedure was only slightly different from those treated using
the LLND procedure. Numerous clinicopathological studies
have demonstrated that the frequency of nodal metastasis in
EGC with mucosal invasion is less than 5%. The degree of
nodal invasion is almost always limited to nl(+), and in less
than 1% of the cases with n2(+) (Habu et al., 1986;
Korenaga et al., 1986). EGC patients with n2(+) would have
been cured only by the ELND procedure but this would have
resulted in a comparatively small improvement in the survival
rate. This relatively small survival benefit must be considered
against the increased operative risks of extended lym-
phadenectomy. Although the operative mortality rate of 2%
associated with the ELND procedure seems to be acceptable,
some researchers have reported that more aggressive surgery
may be related to higher operative morbidity and mortality
(Diggory and Cuschieri, 1985; Heberer et al., 1988; Dent et
al., 1988). In addition, the ELND procedure presents the
disadvantage of longer operation time and greater blood loss,
although these factors were not associated with any increase
in the mortality rate (de Aretxabala et al., 1987; Smith et al.,
1991; Pacelli et al., 1993). Therefore, the most appropriate
treatment in an individual patient with EGC in whom
invasion is limited to the mucosal layer must be determined
after full consideration of all the risks and benefits. Recently,
in some selected cases of gastric mucosal carcinoma,
Japanese surgeons attempted cautiously to perform endo-
scopic mucosal resection or limited surgery such as local
resection, segmental resection, pylorus-preserving gastrec-
tomy and RI gastrectomy. Certainly, such limited procedures
improved patients' quality of life, but the value of limited
procedures should be estimated inclusive of the risk of car-
cinoma recurrence in future.
The distinction of mucosal carcinoma from submucosal
carcinoma is important in limited procedures. Radiographic
or endoscopic diagnosis is often inaccurate. It is not rare for
a tumour that has been grossly diagnosed as mucosal car-
cinoma to infiltrate into the submucosal layer or deeper. We
know for certain that the protruded type EGC less than
2.0 cm in diameter is limited to the mucosa and that it lacks
nodal metastasis (Kitaoka et al., 1984; Korenaga et al., 1986;
Ohta et al., 1987; Iriyama et al., 1989). In addition, if a
tumour shows a depressed differentiated adenocarcinoma less
than 1.0cm in diameter, then it has little chance of nodal
metastasis (Takekoshi et al., 1994). A limited procedure can
be indicated in these cases only. Otherwise, endoscopic ult-
rasonography can be a useful tool for deciding the indication
of limited procedures. Yoshino et al. (1987) reported that the
rate of correct diagnosis in endoscopic ultrasonography was
83.3% in mucosal carcinoma and 71.4% in carcinoma with
submucosal invasion, while the accurate rate of radiographic
examination was 73.0% and 64.7% respectively. The
accuracy of endoscopic ultrasonography in our own exper-
ience was 88.9% in mucosal carcinoma and 62.5% in
submucosal carcinoma. Therefore the accuracy rate of endo-
scopic ultrasonography is higher than that of radiographic
examination, but it is not high enough to be used to indicate
a limited procedure. Further development of instruments for
endoscopic ultrasonography may facilitate more accurate dis-
tinction between these two depths of carcinoma invasion.
In conclusion, our retrospective findings suggest that
aggressive lymph node dissection, in spite of the prolonged
operation time and increased loss of blood, increases the
survival rate of EGC patients with nodal metastasis. On the
other hand, EGC without nodal involvement does not
require any aggressive nodal dissection. We need a search for
a new diagnostic technique to differentiate EGC patients
regarding the presence or absence of nodal metastasis
preoperatively or perioperatively.
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